Inventor · disambiguated record
Salim Yusuf
Also filed as: YUSUF SALIM
4 granted patents·18 pending applications·32 citations·filing 2002–2020
73Inventor score
Files withAVENTIS PHARMA GMBH6BOEHRINGER INGELHEIM INT3SANOFI AVENTIS DEUTSCHLAND3UNIV MCMASTER3Bayer Pharma AG2
Top patents by PatentIndex Score
22 records- 0183US7368469B2Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Granted May 6, 2008·12 cites·94 claims
- 0278US7081347B2Method for predicting cardiovascular eventsUNIV MCMASTER·Filed 2003·Granted Jul 25, 2006·18 cites·8 claims
- 0369US10828310B2Reducing the risk of cardiovascular eventsBayer Pharma AG·Filed 2019·Granted Nov 10, 2020·2 cites·8 claims
- 0467US2008114046A1Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme InhibitorsBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 0564US2007093541A1Pharmaceutical Combination of Angiotensin II Antagonists and Angiotensin I Converting Enzyme InhibitorsBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 0661US2009258919A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and / or congestive heart failureAVENTIS PHARMA GMBH·Filed 2009·Application pending·0 cites
- 0761US2004248968A1Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitorsBOEHRINGER INGELHEIM INT·Filed 2004·Application pending·0 cites
- 0859US2010267798A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTS PHARMA DEUTSCHLAND GMBH·Filed 2009·Application pending·0 cites
- 0958US2008125472A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Application pending·0 cites
- 1057US2008287403A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2008·Application pending·0 cites
- 1153US2006194868A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and /or congestive heart failureSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 1253US2013317047A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTIS PHARMA GMBH·Filed 2012·Application pending·0 cites
- 1352US2005101658A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2004·Application pending·0 cites
- 1451US2021023088A1Reducing the risk of cardiovascular eventsBayer Pharma AG·Filed 2020·Application pending·0 cites
- 1549US2011263619A1Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failureAVENTIS PHARMA GMBH·Filed 2010·Application pending·0 cites
- 1649US2004087645A1Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular eventsAVENTIS PHARMA GMBH·Filed 2003·Application pending·0 cites
- 1748US2010041079A1Method for predicting cardiovascular eventsUNIV MCMASTER·Filed 2009·Application pending·0 cites
- 1848US2004229934A1Method of reducing type 2 diabetes in high risk patientsFiled 2004·Application pending·0 cites
- 1947US7595201B2Device for measuring an analyteUNIV MCMASTER·Filed 2003·Granted Sep 29, 2009·0 cites·9 claims
- 2044US2005065203A1Method of reducing type 2 diabetes in high risk patientsFiled 2002·Application pending·0 cites
- 2142US2008188538A1Methods of lowering glucose levelsGERSTEIN HERTZEL·Filed 2007·Application pending·0 cites
- 2237US2003158223A1Pharmaceutical combination of angiotensin II antagonists and angiotensin I converting enzyme inhibitorsANDERSON CRAIG·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Salim Yusuf files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →